Home Tags Journal of Addiction Medicine
Tag: Journal of Addiction Medicine
6/1/19--Based on a study to examine national trends and contributing factors of cannabis-associated emergency department visits in the United States, cannabis-associated emergency department visits increase monotonically over time. Although vulnerable persons were identified, additional policy or regional factors should explore risks of emergency department visits associated with cannabis use. Read
1/24/19--A study recently published in the Journal of Addiction Medicine reports that youth with single and dual e-cigarette and marijuana use had increased odds of reporting depressive symptoms and suicidality compared to youth who denied use. There is a need for effective prevention and intervention strategies to help mitigate adverse mental health outcomes in this population. Read
Does cannabis use influence opioid outcomes and quality of life among buprenorphine maintained patients?
8/1/18--A recent study, published in the Journal of Addiction Medicine, aimed to assess the pattern of cannabis use among opioid-dependent patients maintained on buprenorphine. Additionally, the study compared the dose of buprenorphine, opioid-related craving and withdrawals, productivity, and quality of life between those with and without recent (past 90-day) cannabis use. The study concluded that cannabis use does not negatively influence opioid outcomes among patients receiving buprenorphine maintenance treatment. Furthermore, there is no difference in productivity and quality of life between individuals maintained on buprenorphine with and without current cannabis use. Read
6/19/17--This commentary suggests that the problem with identifying addiction as a legitimate medical disorder which should be compassionately addressed as a health problem rather than a criminal justice problem may be in the messaging. Furthermore, it states that it would be more persuasive if addiction was recognized as being different from most medical disorders because of its high negative externalities, and that this makes the public more scared of and angry about addiction than they are about conditions like asthma, type II diabetes, and hypertension. Read